CellSource Co., Ltd. (JP:4880) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CellSource Co., Ltd. has announced the establishment of a new subsidiary, Hybrid Medical Co., Ltd., to enhance collaboration with medical institutions in regenerative medicine, especially within orthopedics. The subsidiary will be wholly owned by CellSource and is set to begin operations in November 2024. This strategic move is expected to have a minimal impact on the company’s financial performance for the current fiscal year.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.